| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |